Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc., has reinforced its early stage topical and semi-solids capability by investing in a Becomix homogenizer mixer. The installation and validation of the new equipment extends the company’s ability to manufacture creams, ointments, and semi-solids to support clients’ clinical trial needs and enables it to efficiently deal…
Recipharm Invests in Serialization Solutions
Juniper & Crystec to Create New Drug Development Platform
Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc., will work with CrystecPharma on a major multi-partner project as part of the Advanced Manufacturing Supply Chain Initiative (AMSCI) to help create a new platform to accelerate drug development in the future. Both companies will collaborate as part of this UK-based consortium of partners that includes two…